Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intellectual disability, Wolff type is a rare intellectual disability syndrome characterized by severe intellectual disability, characteristic facial features (low anterior hairline, upward slanting palpebral fissures, ocular hypertelorism, broad, bulbous nose, large ears with helix incompletely developed, thick lips, and micrognathia) and additional anomalies including peripheral joint contractures, delayed skeletal maturation, bilateral cleft lip and palate, strabismus, terminal hypoplasia of fingers, hypospadias, and bilateral inguinal hernias.
Features include: Intellectual disability.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Intellectual disability |
Biomarker and diagnostic research for intellectual disability, Wolff type has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for intellectual disability, Wolff type.
141 publications have been identified in PubMed for intellectual disability, Wolff type. Research spans Review / Meta-Analysis (64%), Basic Science / Preclinical (17%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 90 | 64% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
24 |
17% |
Disease patterns and progression | 10 | 7% |
Patient case studies | 8 | 6% |
New treatment approaches | 5 | 4% |
Other research | 2 | 1% |
Testing and diagnosis research | 2 | 1% |
Ferri C (2026). [PMID: 41798958](https://pubmed.ncbi.nlm.nih.gov/41798958/). *Front Immunol*. [Review / Meta-Analysis]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Donaldson S (2026). [PMID: 42186234](https://pubmed.ncbi.nlm.nih.gov/42186234/). *Arch Clin Neuropsychol*. [Case Report / Case Series]
Mountford R (2026). [PMID: 41637667](https://pubmed.ncbi.nlm.nih.gov/41637667/). *Eur J Pain*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Gene Therapy / Novel Therapeutics]
Sakuma H (2025). [PMID: 39143740](https://pubmed.ncbi.nlm.nih.gov/39143740/). *Dev Med Child Neurol*. [Review / Meta-Analysis]
Cheng LG (2025). [PMID: 40122225](https://pubmed.ncbi.nlm.nih.gov/40122225/). *Fertil Steril*. [Review / Meta-Analysis]
AI-curated news mentioning intellectual disability, Wolff type
Updated Mar 23, 2026
A study identifies a heterozygous loss-of-function variant in the METTL5 gene linked to intellectual disability. This discovery adds to the understanding of genetic factors contributing to cognitive impairments.
Recent research identifies mutations in the KIF11 gene that cause intellectual disability by disrupting microtubule dynamics and dendritic arborization. This discovery enhances understanding of the molecular mechanisms underlying this condition.
Research identifies bi-allelic GSPT1 variants linked to a syndromic neurodevelopmental disorder, which includes symptoms of intellectual disability and microcephaly. This discovery enhances understanding of genetic factors in rare neurodevelopmental conditions.
A recent systematic review confirms that the use of paracetamol during pregnancy does not increase the risk of autism, ADHD, or intellectual disability. The EMA maintains that paracetamol is a crucial option for managing pain or fever in pregnant women based on extensive scientific data.